Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: A phase I study

Annals of Oncology

Volumn 7, Issue 3, 1996, Pages 314-316

  Hoffman, P C ^a,d   Masters, G A ^a   Drinkard, L C ^a   Krauss, S A ^b   Samuels, B L ^c   Golomb, H M ^a   Yokes, E E ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b WEISS MEMORIAL HOSPITAL   (United States)

^c ADVOCATE LUTHERAN GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Chemotherapy; Ifosfamide paclitaxel; Non small cell lung cancer

Indexed keywords

CISPLATIN; DEXAMETHASONE; DIPHENHYDRAMINE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MESNA; PACLITAXEL; RANITIDINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; NEUROTOXICITY; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA;

EID: 0029964170     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010578     Document Type: Article

References (9)

1. Ettinger DS. Ifosfamide in the treatment of non-small-cell lung cancer. Semin Oncol 1989; 16(1) (Suppl 3): 31-8.
2. Johnson DH. Overview of ifosfamide in small-cell and non-small-cell lung cancer. Semin Oncol 1990; 17(2) (Suppl 4): 24-30.
3. Eberhardt W, Niederle N. Ifosfamide in non-small-cell lung cancer: A review. Semin Oncol 1992; 19(1) (Suppl 1): 40-8.
4. Shepherd FA, Evans WK, Goss PE et al. Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small-cell lung cancer. Semin Oncol 1992; 19(1) (Suppl 1): 54-8.
5. Shirinian M, Lee JS, Dhingra HH et al. Phase II study of cisplatin, ifosfamide, and etoposide combination for advanced non-small-cell lung cancer: Final report. Semin Oncol 1992; 19(6) (Suppl 12): 58-63.
6. Murphy WK, Fossella FV, Winn RJ et al. Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer. J Natl Cancer Inst 1993; 85: 384-8.
7. Chang AY, Kim K, Click J et al. Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer. The Eastern Cooperative Oncology Group results. J Natl Cancer Inst 1993; 85: 388-94.
8. Hoffman PC, Drinkard LC, Masters GA et al. Ifosfamide plus Navelbine: A phase I study in advanced non-small-cell lung cancer. Proc Am Soc Clin Oncol 1995; 14: 358.
9. Vokes EE, Hoffman PC, Masters GA et al. Ifosfamide-based chemotherapy for non-small-cell lung cancer: Phase I/II studies at The University of Chicago. Semin Oncol 1996; in press.